Search Results 271-280 of 17652 for Glucocorticoids

  1. Emricasan, A Caspase Inhibitor, For Evaluation In Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Systemic glucocorticoids for more than 4 weeks at doses greater than replacement doses. Uncontrolled diabetes (HbA1c ≥9%) within 60 days prior to day 1 ...

  2. Role of the Gut Microbiome in Pulmonary Hypertension - Mayo Clinic

    Currently taking a medication (e.g., antibiotic, anti-inflammatory agents, glucocorticoids or other immune modulating medications). Unwilling to discontinue ...

  3. Glaucoma Biomarkers - Mayo Clinic

    Use of any glucocorticoid by any route. Subject must be washed out of the glucocorticoid for at least 2 weeks before study entry. Participating Mayo Clinic ...

  4. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Have received prior therapy with an immunomodulatory agent, a proteosome inhibitor, and glucocorticoids; Absolute neutrophil count (ANC) ≥ 1000/uL ...

  5. Beta-Blockers and Bone Health - Mayo Clinic

    History of current or past chronic glucocorticoid use (>3 months); On pharmacologic doses of thyroid replacement; Current users of teraparatide, denosumab ...

  6. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

    Taking IS therapy (e.g., glucocorticoids, CsA, Tac, mycophenolate, or TNF inhibitors). Positive Hemoglobin-Solubility (e.g., SickleDex™ or equivalent) test ...

  7. Visionary Study: Phase 3 Trial of Sibeprenlimab in Immunoglobulin A Nephropathy (IgAN) - Mayo Clinic

    - Chronic systemic immunosuppression, including glucocorticoids, within 16 weeks of randomization. - Participation in another interventional clinical trial ...

  8. A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) - Mayo Clinic

    - Previous orbital irradiation or orbital surgery. - Any glucocorticoid use (intravenous [IV] or oral) with a cumulative dose equivalent to >= 1g of ...

  9. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  10. Imaging Studies In Corticobasal Syndrome - Mayo Clinic

    ... glucocorticoid, steroidal or non-steroidal anti-inflammatory medication within 2 weeks of scanning. Note: Other protocol defined Inclusion/Exclusion Criteria ...